Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Lazurite Holdings had announced its collaboration with UH Ventures on a human factors study of the ArthroFree™ system in August.
9T Labs notes the investment will help fully commercialize the company’s Red Series® software tools, 3D printer, and molding equipment to lead the way in the production of sustainable high-performance parts for end-use applications.
The EarliPoint® Evaluation for Autism Spectrum Disorder is an investigational device utilizing Dynamic Quantification of Social-Visual Engagement (DQSVE), to capture moment-by-moment looking behavior imperceptible to the human eye.